Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | SLC29A1 | Q99808 | 15/20 | 0.71 |
| ▸ | STAT6 | P42226 | 2/20 | 0.69 |
| ▸ | DPP4 | P27487 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.69 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.69 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.69 |
| ▸ | GAPDH | P04406 | 1/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.69 |
| ▸ | PI4KA | P42356 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.69 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.69 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL672036 | 1.00 | SMN1; SMN2 (0.77) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL7134319 | 1.00 | SMN1; SMN2 (0.77) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL672035 | 1.00 | SMN1; SMN2 (0.77) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL30089484 | 1.00 | SMN1; SMN2 (0.77) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL240981 | 1.00 | SMN1; SMN2 (0.77) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL26294910 | 0.91 | SMN1; SMN2 (0.67) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL8500982 | 0.90 | SLC29A1 (0.78) | SMN1; SMN2SLC29A1STAT6DPP4MEN1 | |
| SCHEMBL2580672 | 0.90 | SMN1; SMN2 (0.72) | SMN1; SMN2TP53SLC29A1STAT6DPP4 | |
| SCHEMBL9350374 | 0.89 | SLC29A1 (0.74) | SMN1; SMN2SLC29A1STAT6DPP4MEN1 | |
| SCHEMBL9347373 | 0.89 | SLC29A1 (0.74) | SMN1; SMN2SLC29A1STAT6DPP4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190225643-A1 | NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT | CORNELL UNIVERSITY (US) | 2019-07-25 | — | — | US | disclosed |
| WO-2017180981-A1 | NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT | CORNELL UNIVERSITY (US) | 2017-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225643-A1 | NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT | DCK, NME4, ENTPD5 | SMN1; SMN2 358/4885TP53 1573/4885SLC29A1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.